Clinical trial
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
NCT00490789 · Cardiff University, Other · Unknown status
Key facts
| NCT number | NCT00490789 |
|---|---|
| Title | Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM |
| Official title | A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis |
| Acronym | TESSTAL |
| Lead sponsor | Cardiff University, Other |
| Collaborators | University of Nottingham St Georges Hospital Medical School Royal Sussex County Hospital The Tuberous Sclerosis Association Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberous Sclerosis, Lymphangioleiomyomatosis |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 14 |
| Start date | Oct 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 25, 2007 |
| Last update posted | Apr 30, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: